Whittier Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-58,148
Closed -$5.77M 1674
2019
Q3
$5.77M Buy
58,148
+86
+0.1% +$8.17K 0.17% 135
2019
Q2
$5.37M Buy
58,062
+214
+0.4% +$20.3K 0.16% 143
2019
Q1
$5.46M Sell
57,848
-274
-0.5% -$24K 0.17% 136
2018
Q4
$3.73M Sell
58,122
-4,124
-7% -$304K 0.13% 154
2018
Q3
$5.57M Sell
62,246
-1,034
-2% -$91.4K 0.17% 137
2018
Q2
$5.03M Sell
63,280
-2,560
-4% -$213K 0.17% 135
2018
Q1
$5.87M Buy
65,840
+3,638
+6% +$349K 0.2% 124
2017
Q4
$6.49M Sell
62,202
-53,113
-46% -$5.99M 0.23% 119
2017
Q3
$16.8M Buy
115,315
+1,102
+1% +$150K 0.61% 41
2017
Q2
$14.8M Buy
114,213
+2,163
+2% +$265K 0.57% 42
2017
Q1
$13.9M Sell
112,050
-11,383
-9% -$1.36M 0.56% 44
2016
Q4
$14.3M Buy
123,433
+1,810
+1% +$202K 0.61% 42
2016
Q3
$12.7M Sell
121,623
-544
-0.4% -$58.9K 0.55% 48
2016
Q2
$12M Buy
122,167
+892
+0.7% +$92.3K 0.53% 49
2016
Q1
$12.1M Buy
121,275
+7,045
+6% +$725K 0.54% 53
2015
Q4
$13.7M Buy
114,230
+12,339
+12% +$1.43M 0.62% 40
2015
Q3
$11M Buy
101,891
+8,609
+9% +$1.07M 0.54% 51
2015
Q2
$10.8M Buy
93,282
+14,806
+19% +$1.69M 0.48% 56
2015
Q1
$9.05M Sell
78,476
-319
-0.4% -$38.1K 0.41% 66
2014
Q4
$8.81M Sell
78,795
-389
-0.5% -$41K 0.42% 66
2014
Q3
$7.5M Sell
79,184
-1,282
-2% -$116K 0.37% 74
2014
Q2
$6.91M Buy
80,466
+202
+0.3% +$15.4K 0.34% 83
2014
Q1
$5.6M Sell
80,264
-1,072
-1% -$84.9K 0.29% 99
2013
Q4
$6.87M Sell
81,336
-8,818
-10% -$698K 0.35% 82
2013
Q3
$6.95M Sell
90,154
-2,236
-2% -$157K 0.38% 77
2013
Q2
$5.4M Buy
+92,390
New +$5.56M 0.3% 90

Other funds holding CELG

Whittier Trust's CELG Position: Q4 2019 in Review

Whittier Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 58,148 shares — an estimated $5.77M sold.

Whittier Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $16.8M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Whittier Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Whittier Trust sold 58,148 Celgene Corp shares in Q4 2019, an estimated $5.77M.
  • Whittier Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Whittier Trust's Celgene Corp position peaked at $16.8M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Whittier Trust's 13F filing for Q4 2019, filed 31 Jan 2020.